Dallah Healthcare Co. (4004) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 8.34%

The company has been able to generate a Return on Capital Employed (avg) of 8.34% signifying low profitability per unit of total capital (equity and debt)

High Debt Company with a Debt to Equity ratio (avg) at times

Flat results in Jun 25

With ROE of 12.61%, it has a very attractive valuation with a 3.65 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

SAR 12,158 Million (Small Cap)

P/E

29.00

Industry P/E

Dividend Yield

1.29%

Debt Equity

0.73

Return on Equity

12.58%

Price to Book

2.88

Revenue and Profits:

Net Sales:

1,062 Million

(Quarterly Results - Jun 2025)

Net Profit:

128 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-6.92%

6 Months

4.85%

1 Year

-23.22%

2 Years

-30.46%

3 Years

-21.33%

4 Years

60.69%

5 Years

146.94%

Dallah Healthcare Co. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

24.54%

EBIT Growth (5y)

27.51%

EBIT to Interest (avg)

5.79

Debt to EBITDA (avg)

3.71

Net Debt to Equity (avg)

0.72

Sales to Capital Employed (avg)

0.55

Tax Ratio

3.87%

Dividend Payout Ratio

41.40%

Pledged Shares

Institutional Holding

ROCE (avg)

8.34%

ROE (avg)

11.48%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.65

EV to EBIT

34.15

EV to EBITDA

25.59

EV to Capital Employed

2.53

EV to Sales

5.10

PEG Ratio

2.69

Dividend Yield

1.29%

ROCE (Latest)

7.40%

ROE (Latest)

12.61%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 38.84% vs 14.14% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 5.80% vs 98.52% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,062.40",
          "val2": "765.20",
          "chgp": "38.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "209.90",
          "val2": "170.20",
          "chgp": "23.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "46.30",
          "val2": "25.40",
          "chgp": "82.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "127.70",
          "val2": "120.70",
          "chgp": "5.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "139.00%",
          "val2": "177.30%",
          "chgp": "-3.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.93% vs 18.28% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 25.90% vs 30.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,205.70",
          "val2": "2,942.90",
          "chgp": "8.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "682.50",
          "val2": "600.20",
          "chgp": "13.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "106.70",
          "val2": "104.10",
          "chgp": "2.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "485.20",
          "val2": "385.40",
          "chgp": "25.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "169.10%",
          "val2": "161.30%",
          "chgp": "0.78%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

1,062.40

765.20

38.84%

Operating Profit (PBDIT) excl Other Income

209.90

170.20

23.33%

Interest

46.30

25.40

82.28%

Exceptional Items

0.00

Consolidate Net Profit

127.70

120.70

5.80%

Operating Profit Margin (Excl OI)

139.00%

177.30%

-3.83%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 38.84% vs 14.14% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 5.80% vs 98.52% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

3,205.70

2,942.90

8.93%

Operating Profit (PBDIT) excl Other Income

682.50

600.20

13.71%

Interest

106.70

104.10

2.50%

Exceptional Items

0.00

Consolidate Net Profit

485.20

385.40

25.90%

Operating Profit Margin (Excl OI)

169.10%

161.30%

0.78%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 8.93% vs 18.28% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 25.90% vs 30.47% in Dec 2023

All Annual Results

Company CV

About Dallah Healthcare Co.

Dallah Healthcare Co.

Hospital

No Details Available.

Company Coordinates

No Company Details Available